WINDTREE THERAPEUTICS INC /DE/ Interest Expense Nonoperating
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Interest Expense Nonoperating of $328.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ interest expense nonoperating for the quarter ending 2025-09-30 was $328.00K, a 543.14% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ interest expense nonoperating for the quarter ending 2025-06-30 was $79.00K, a 28.18% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ interest expense nonoperating for the quarter ending 2025-03-31 was $20.00K, a 53.85% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ interest expense nonoperating for the quarter ending 2024-12-31 was $61.00K, a 408.33% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ interest expense nonoperating for fiscal 2024 was $235.00K, a 370.00% increase from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ interest expense nonoperating for fiscal 2023 was $50.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-09-30 | $328.00K 10-Q · filed 2025-11-19 | $407.00K derived: sum of 2 quarters · filed 2025-11-19 | $427.00K 10-Q · filed 2025-11-19 | $488.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-06-30 | $79.00K 10-Q · filed 2025-08-19 | $99.00K 10-Q · filed 2025-08-19 | $160.00K derived: sum of 3 quarters · filed 2025-08-19 | $211.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-03-31 | $20.00K 10-Q · filed 2025-05-15 | $81.00K derived: sum of 2 quarters · filed 2025-05-15 | $132.00K derived: sum of 3 quarters · filed 2025-11-19 | $242.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $112.00K derived: sum of 2 quarters · filed 2025-11-19 | $222.00K derived: sum of 3 quarters · filed 2025-11-19 | $235.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | $51.00K 10-Q · filed 2025-11-19 | $161.00K derived: sum of 2 quarters · filed 2025-11-19 | $174.00K 10-Q · filed 2025-11-19 | $186.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $110.00K 10-Q · filed 2025-08-19 | $123.00K 10-Q · filed 2025-08-19 | $135.00K derived: sum of 3 quarters · filed 2025-08-19 | $148.00K derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $13.00K 10-Q · filed 2025-05-15 | $25.00K derived: sum of 2 quarters · filed 2025-05-15 | $38.00K derived: sum of 3 quarters · filed 2025-05-15 | $51.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $25.00K derived: sum of 2 quarters · filed 2025-04-15 | $38.00K derived: sum of 3 quarters · filed 2025-04-15 | $50.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $13.00K 10-Q · filed 2024-11-26 | $26.00K derived: sum of 2 quarters · filed 2024-11-26 | $38.00K 10-Q · filed 2024-11-26 | |
| 2023-06-30 | $13.00K 10-Q · filed 2024-08-19 | $25.00K 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |